Physician profile
Mark D Goldberg
NPI 1144238312
$1,794.46
in general payments reported to CMS, 2019-2025
21 companies · $24.10 in 2025
The $24.10 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $669 · 2020: $97.67 · 2021: $262 · 2022: $378 · 2023: $205 · 2024: $158 · 2025: $24.10.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $388.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $387.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amarin Pharma, INC. | $418.26 | 2019-2021 | |
| Sunovion Pharmaceuticals INC. | $202.65 | 2019-2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $173.35 | 2020-2024 | Jardiance |
| Novo Nordisk INC | $148.49 | 2019-2023 | |
| Inari Medical, INC. | $137.39 | 2024 | Flowtriever Catheter, S, Ct Thrombectomy System Kit |
| Penumbra, INC. | $128.35 | 2022 | |
| Glaxosmithkline, LLC. | $118.20 | 2019-2022 | |
| Abbvie INC. | $99.55 | 2021-2022 | |
| Medtronic Vascular, INC. | $85.01 | 2019 | |
| Janssen Pharmaceuticals, INC | $63.42 | 2021-2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $48.34 | 2019-2021 | |
| Kowa Pharmaceuticals America, INC. | $29.62 | 2020-2022 | |
| Boston Scientific Corporation | $24.10 | 2025 | Watchman Access System |
| Esperion Therapeutics, INC. | $19.77 | 2021 | |
| Sumitomo Pharma America, INC. | $17.75 | 2023 | Gemtesa |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $15.22 | 2021 | |
| Pfizer INC. | $15.04 | 2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $12.93 | 2022 | |
| E.R. Squibb & Sons, L.L.C. | $12.55 | 2019 | |
| Echosens North America, INC. | $12.26 | 2022 | |
| Lucid Diagnostics INC. | $12.21 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Goldberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.